Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.
<h4>Background</h4>Human cathelicidin LL-37 is a cationic antimicrobial peptide (AMP) which possesses a variety of activities including the ability to neutralise endotoxin. In this study, we investigated the role of LPS neutralisation in mediating LL-37's ability to inhibit Pseudomo...
Guardado en:
Autores principales: | Aaron Scott, Sinéad Weldon, Paul J Buchanan, Bettina Schock, Robert K Ernst, Danny F McAuley, Michael M Tunney, Chris R Irwin, J Stuart Elborn, Clifford C Taggart |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d935bca1e2e944898c006e6fb0657907 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
por: Sadeghi S, et al.
Publicado: (2019) -
Antibacterial and osteogenesis performances of LL37-loaded titania nanopores in vitro and in vivo
por: Shen X, et al.
Publicado: (2019) -
The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure
por: Yizhaq Engelberg, et al.
Publicado: (2020) -
Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13
por: Katarzyna Niemirowicz, et al.
Publicado: (2017) -
Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis
por: Franziska Herster, et al.
Publicado: (2020)